Stem cell treatment is the use of stem cells to treat or stop a ailment or condition. Bone marrow transplant is the most broadly utilized stem-cell treatment, but some therapies derived from umbilical cord blood are also in use. Analysis is underway to develop a variety of sources for stem cells, as properly as to apply stem-cell treatments for neurodegenerative diseases and situations such as diabetes and heart ailment, between others.

Stem-cell treatment has turn into controversial following developments such as the capability of scientists to isolate and culture embryonic stem cells, to generate stem cells using somatic cell nuclear transfer and their use of methods to generate induced pluripotent stem cells. This controversy is usually associated to abortion politics and to human cloning. Additionally, efforts to marketplace treatments based on transplant of stored umbilical cord blood have been controversial.

For above thirty years, bone marrow has been employed to treat individuals with cancer with situations such as leukaemia and lymphoma this is the only form of stem-cell treatment that is broadly practiced. During chemotherapy, most expanding cells are killed by the cytotoxic agents. These agents, nonetheless, can not discriminate amongst the leukaemia or neoplastic cells, and the hematopoietic stem cells within the bone marrow. It is this side result of typical chemotherapy approaches that the stem-cell transplant attempts to reverse a donor’s wholesome bone marrow reintroduces functional stem cells to substitute the cells misplaced in the host’s physique for the duration of therapy. The transplanted cells also make an immune response that aids to kill off the cancer cells this procedure can go as well far, nonetheless, leading to graft vs host ailment, the most severe side result of this therapy.

One more stem cell treatment referred to as Prochymal, was conditionally authorized in Canada in 2012 for the management of acute graft-vs-host ailment in young children who are unresponsive to steroids. It is an allogenic stem treatment based on mesenchymal stem cells (MSCs) derived from the bone marrow of grownup donors. MSCs are purified from the marrow, cultured and packaged, with up to 10,000 doses derived from a single donor. The doses are stored frozen until finally essential.

The FDA has authorized five hematopoietic stem-cell goods derived from umbilical cord blood, for the therapy of blood and immunological diseases.

In 2014, the European Medicines Agency suggested approval of limbal stem cells for individuals with significant limbal stem cell deficiency due to burns in the eye.